Taniguchi Hirokazu, Kimura Yutaka, Kim Chiwan, Danno Katsuki, Kagara Naofumi, Kanoh Toshiyuki, Ohnishi Tadashi, Tohno Takeshi, Nakano Yoshiaki, Monden Takushi, Imaoka Shingi
Dept. of Surgery, NTT West Osaka Hospital.
Gan To Kagaku Ryoho. 2011 Nov;38(12):1954-6.
A 63-year-old male admitted for hematemesis was diagnosed with type 3 advanced gastric cancer located in the upper and middle body of the stomach in an endoscopic examination. Abdominal computed tomography demonstrated lymph nodes metastasis and a splenic vein thrombus. Since curative resection was not deemed possible, we performed neoadjuvant chemotherapy using S-1 (120 mg, day 1-21) plus CPT-11 (135 mg, day 1 and 15) except for down-staging. After 4 courses of chemotherapy, gastric tumor and metastatic lymph nodes were reduced in size and the splenic vein thrombus was disappeared, and then total gastrectomy was performed (tub2, T2 (MP) N0 H0 M0 P0 CY0, Stage IB). S-1 medication was applied as adjuvant chemotherapy. Forty months passed from the operation, the patient remains alive with no signs of relapse.
一名因呕血入院的63岁男性在内镜检查中被诊断为位于胃体中上段的3型进展期胃癌。腹部计算机断层扫描显示有淋巴结转移和脾静脉血栓形成。由于认为无法进行根治性切除,我们除了进行降期治疗外,还使用S-1(120毫克,第1 - 21天)加CPT-11(135毫克,第1天和第15天)进行新辅助化疗。化疗4个疗程后,胃肿瘤和转移淋巴结缩小,脾静脉血栓消失,随后进行了全胃切除术(tub2,T2(MP)N0H0M0P0CY0,ⅠB期)。应用S-1进行辅助化疗。手术后40个月,患者仍然存活,没有复发迹象。